Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted M Ross

Showing results (191-200 of 345) with videos related to

Pageof 35
Sort By:
Ebiomedicine|December 13, 2021
Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sexJuanjie Tang, Gabrielle Grubbs, Youri Lee, et al.
Vaccine|December 3, 2014
Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccineDonald M Carter, Chalise E Bloom, Greg A Kirchenbaum, et al.
Biorxiv : the Preprint Server for Biology|June 8, 2021
Functional characterization of SARS-CoV-2 vaccine elicited antibodies in immunologically naïve and pre-immune humansDavid Forgacs, Hyesun Jang, Rodrigo B Abreu, et al.
Vaccine|March 11, 2026
Synthetic TRAC478 emulsion and saponin based adjuvant systems enhance humoral and cellular immune responses elicited by computationally optimized H1 and H3 hemagglutinin subunit vaccinesJames D Allen, Camila Caetano, Cherrokee M Sands, et al.
Journal of Proteome Research|June 2, 2022
Template-Assisted <i>De Novo</i> Sequencing of SARS-CoV-2 and Influenza Monoclonal Antibodies by Mass SpectrometryMichelle V Gadush, Giuseppe A Sautto, Hamssika Chandrasekaran, et al.
Frontiers in Immunology|October 14, 2021
SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune HumansDavid Forgacs, Hyesun Jang, Rodrigo B Abreu, et al.
Human Vaccines & Immunotherapeutics|August 27, 2019
Computationally optimized broadly reactive vaccine based upon swine H1N1 influenza hemagglutinin sequences protects against both swine and human isolated virusesAmanda L Skarlupka, Simon O Owino, Lui P Suzuki-Williams, et al.
Immunohorizons|April 26, 2019
Elicitation of Broadly Protective Antibodies following Infection with Influenza Viruses Expressing H1N1 Computationally Optimized Broadly Reactive Hemagglutinin AntigensGiuseppe A Sautto, Greg A Kirchenbaum, Jeffrey W Ecker, et al.
Virology Journal|May 14, 2010
Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in miceMatthew D Dunn, Shannan L Rossi, Donald M Carter, et al.
Comparative Immunology, Microbiology and Infectious Diseases|June 26, 2026
Comparison of Igκ and Igλ binding toward influenza virus hemagglutinin and SARS-CoV-2 Spike protein during primary viral infections in humans, mice, and pigsRobert A Richardson, J Fletcher North, Matthew H Thomas, et al.
Pageof 35

Showing results (191-200 of 345) with videos related to

Sort By:
Pageof 35
Ebiomedicine|December 13, 2021
Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sexJuanjie Tang, Gabrielle Grubbs, Youri Lee, et al.
Vaccine|December 3, 2014
Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccineDonald M Carter, Chalise E Bloom, Greg A Kirchenbaum, et al.
Biorxiv : the Preprint Server for Biology|June 8, 2021
Functional characterization of SARS-CoV-2 vaccine elicited antibodies in immunologically naïve and pre-immune humansDavid Forgacs, Hyesun Jang, Rodrigo B Abreu, et al.
Vaccine|March 11, 2026
Synthetic TRAC478 emulsion and saponin based adjuvant systems enhance humoral and cellular immune responses elicited by computationally optimized H1 and H3 hemagglutinin subunit vaccinesJames D Allen, Camila Caetano, Cherrokee M Sands, et al.
Journal of Proteome Research|June 2, 2022
Template-Assisted <i>De Novo</i> Sequencing of SARS-CoV-2 and Influenza Monoclonal Antibodies by Mass SpectrometryMichelle V Gadush, Giuseppe A Sautto, Hamssika Chandrasekaran, et al.
Frontiers in Immunology|October 14, 2021
SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune HumansDavid Forgacs, Hyesun Jang, Rodrigo B Abreu, et al.
Human Vaccines & Immunotherapeutics|August 27, 2019
Computationally optimized broadly reactive vaccine based upon swine H1N1 influenza hemagglutinin sequences protects against both swine and human isolated virusesAmanda L Skarlupka, Simon O Owino, Lui P Suzuki-Williams, et al.
Immunohorizons|April 26, 2019
Elicitation of Broadly Protective Antibodies following Infection with Influenza Viruses Expressing H1N1 Computationally Optimized Broadly Reactive Hemagglutinin AntigensGiuseppe A Sautto, Greg A Kirchenbaum, Jeffrey W Ecker, et al.
Virology Journal|May 14, 2010
Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in miceMatthew D Dunn, Shannan L Rossi, Donald M Carter, et al.
Comparative Immunology, Microbiology and Infectious Diseases|June 26, 2026
Comparison of Igκ and Igλ binding toward influenza virus hemagglutinin and SARS-CoV-2 Spike protein during primary viral infections in humans, mice, and pigsRobert A Richardson, J Fletcher North, Matthew H Thomas, et al.
Pageof 35